Literature DB >> 598751

Inhibition of the fibrinolytic system in Behçet's disease?

F Asbeck, D Meyer-Boernecke, J van de Loo.   

Abstract

Suppression of the fibrinolytic system is a well-known phenomenon in patients with Behçet's disease. It is generally explained by an increase in the inhibitory potential. In order to prove this theory, the fibrinolytic system was investigated in 5 male patients with severe chronic Behçet's disease. By the venous occlusion test, a marked suppression of the activatability of the system could be demonstrated (euglobulin lysis time, various fibrin plate assays). Results of analysis of the known inhibitors could not explain the phenomenon: antithrombin III, alpha2-macroglobulin, fast-reacting alpha2-antiplasmin, C1 inactivator, and the plasmin-antiplasmin complex were normal. The only change was an elevation of alpha1-antitrypsin and fibrinogen in 4 patients possibly due to an acute phase reaction. In addition to the possibility of a hitherto unidentified inhibitor, therefore, a decrease in production or in release of vessel wall activators must also be considered in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 598751     DOI: 10.1159/000214195

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  2 in total

1.  Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.

Authors:  R Aitchison; P Chu; D R Cater; R J Harris; R J Powell
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

2.  Vascular involvement in Behçet's disease: 8-year audit.

Authors:  M A Kuzu; C Ozaslan; C Köksoy; A Gürler; A Tüzüner
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.